SEPTIN7P15

Across TCGA pan-cancer cohorts, SEPTIN7P15 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SEPTIN7P15 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher SEPTIN7P15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SEPTIN7P15 expression acts as an unfavorable survival marker.

OV, BLCA, and STAD are the cancer types where SEPTIN7P15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	II,III,IV	0.376	0.547	.006	108	view →
BLCA	OS	Tertile	IV	0.130	0.599	.002	36	view →
STAD	DFS	Tertile	III,IV	0.331	0.633	.003	27	view →
UCEC	DFS	Tertile	All	0.139	0.650	.001	24	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →
HNSC	OS	Tertile	II,III,IV	0.160	0.401	.028	9	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	9	view →
CESC	OS	Tertile	All	0.216	0.596	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

SEPTIN7P15–OV (DFS)

Open the OV breakdown →